Clinical Trial Update: "Randomized Controlled Trial Testing the Efficacy of Corticosteroid Therapy Versus Placebo in Fibrotic Hypersensitivity Pneumonitis" [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial is evaluating corticosteroid therapy versus placebo for fibrotic hypersensitivity pneumonitis and is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypersensitivity Pneumonitis

Drugs mentioned

• Corticosteroid therapy (corticosteroid)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Hypersensitivity Pneumonitis | Phase 3 | Status: NOT_YET_RECRUITING